Results 221 to 226 of about 3,235 (226)

Early response to Tezepelumab in type-2 severe asthma patients non-responders to other biological treatments: a real-life study

Journal of Asthma
Miguel Jiménez Gomez
exaly  

Adverse events associated with tezepelumab: a safety analysis of clinical trials and a pharmacovigilance system

Expert Opinion on Drug Safety
Wenhui Liao, Huiguo Liu, Fengqin Zhang   +2 more
exaly  

Exploratory analysis of the economically justifiable price of tezepelumab for asthma severe in Colombia

Journal of Asthma
Andres F Zuluaga, Jefferson Antonio Buendia   +1 more
exaly  

Clarification of the efficacy of tezepelumab in the phase 2a COURSE trial

Journal of Allergy and Clinical Immunology
Dave, Singh, MeiLan K, Han, Jean-Pierre, Llanos, Neil, Martin, Amit, Parulekar, Konstantinos, Kostikas, Sandhia S, Ponnarambil   +6 more
openaire   +2 more sources

COURSE: Encouraging results for tezepelumab in COPD

Medicom Conference Report ATS 2024
openaire   +1 more source

Population Pharmacokinetic Modeling and Exposure–Efficacy and Body Weight–Response Analyses for Tezepelumab in Patients With Severe, Uncontrolled Asthma

Journal of Clinical Pharmacology
exaly